Psychometric Evaluation of a Turkish Version of the Diabetes Fear of Self-injecting and Self-testing Questionnaire (D-FISQ)

Celik, RN Selda; Pınar, Rukiye

doi:10.1016/j.anr.2016.06.001

Cited by 8 publications

(10 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Articles included 24 cross-sectional studies [ 1 – 3 , 25 , 26 , 28 – 30 , 33 , 36 , 37 , 39 – 45 , 47 , 50 – 52 ], one abstract of a literature review [ 38 ], one prospective cohort study [ 34 ], two case reports [ 31 , 48 ], one randomized controlled trial [ 24 ], and three reports [ 27 , 32 , 49 ]. The included studies used a variety of methodology to define and assess needle fear or phobia, ranging from a single question within a broader questionnaire, face-to face interviews to assessment of fear or phobia using a dedicated validated tool (eg.…”

Section: Resultsmentioning

confidence: 99%

The prevalence and evidence-based management of needle fear in adults with chronic disease: A scoping review

et al. 2021

View full text Add to dashboard Cite

Background Little is known about the prevalence and best management of needle fear in adults with chronic disease, who may experience frequent and long-term exposure to needles for lifesaving therapies such as renal dialysis and cancer treatment. Identifying interventions that assist in management of needle fear and associated distress is essential to support these patients with repeated needle and cannula exposure. Method We followed the PRISMA methodology for scoping reviews and systematically searched PsychINFO, PubMed (MEDLINE), ProQuest, Embase and grey literature and reference lists between 1989 and October 2020 for articles related to needle discomfort, distress, anxiety, fear or phobia. The following chronic diseases were included: arthritis, asthma, chronic back pain, cancer, cardiovascular disease, chronic obstructive pulmonary disease, diabetes, and mental illness, or kidney failure. Literature concerning dentistry, vaccination, intravenous drug users and paediatric populations were excluded. Results We identified 32 papers reporting prevalence (n = 24), management (n = 5) or both (n = 3). Needle fear prevalence varied in disease cohorts: 17–52% (cancer), 25–47% (chronic kidney disease) and 0.2–80% (diabetes). Assessment methods varied across studies. Management strategies had poor evidence-base, but included needle-specific education, decorated devices, cognitive-behavioural stress management techniques, distraction, and changing the therapy environment or modality. Conclusion Although needle fear is common there is a paucity of evidence regarding interventions to address it among adults living with chronic disease. This scoping review has highlighted the need for improved identification of needle fear in adults and development of interventions are required for these cohorts.

show abstract

Section: Resultsmentioning

confidence: 99%

The prevalence and evidence-based management of needle fear in adults with chronic disease: A scoping review

et al. 2021

View full text Add to dashboard Cite

show abstract

“…Higher scores indicate more fear. As the number of the cases who responded as "0" was high in the present study, and the score estimation of the sub-and main dimensions was made as mean rst; the responses were re-coded as 1= almost never, 2= sometimes, 3= frequently, 4= almost always, and the mean values were estimated based on this in accordance with the recommendations of the statistical specialist [10]. While the Cronbach alpha value was 0.96 for Total D-FISQ, 0.93 for FSI and 0.95 for FST in the study of Çelik [10], they were found to be 0.95 for FSI, 0.80 for FST and 0.85 for total D-FISQ.…”

Section: Data Collection Toolsmentioning

confidence: 90%

“…Diabetes Fear of Injecting and Self-Testing Questionnaire (D-FISQ) was developed by Snoek et al with the aim of investigating the fear of self-injecting and self-testing [9]. The Turkish reliability and validity study of the scale was conducted by Çelik [10] and then published by Çelik and Pınar [11]. D-FSIQ, which includes 15 statements is composed of two sub-dimensions including the fear of self-injecting (6 statements) and fear of-self-testing (9 statements).…”

Section: Data Collection Toolsmentioning

confidence: 99%

Association between accepting the illness and effective insulin administration in patients with type 2 Diabetes Mellitus

BİNAY¹,

Aştı²

2021

Preprint

View full text Add to dashboard Cite

Purpose To investigate the association between individual, disease-related and care-related properties of the individuals and their accepting the disease, and effective insulin administration. Methods 103 diabetic patients were included in the study. The Acceptance of Illness Scale (AIS) and the Diabetes Fear of Injecting and Self-Testing Questionnaire (D-FISQ) were used for the data collection. The data were analyzed using the descriptive statistics. Results The Cronbach alpha was 0.96 for AIS, 0.95 for fear of self-injecting (FSI), 0.80 for fear of self-testing (FST) and 0.85 for total D-FISQ. A negative association was determined between the AIS score, and FSI, FST, total D-FISQ; a positive statistically significant association was found between the FSI score and FST, total D-FISQ scores and between FST and the total D-FISQ scores. The FSI score was found to be higher among females; the AIS scores of the patients who were not measuring the plasma glucose before insulin injection were found to be higher; the FSI scores of the patients who received help for insulin injection were found to be higher. Conclusion Accepting the disease affects an effective insulin administration behavior. Hence, nursing care and education of the individuals should be planned and implemented so as to improve the acceptance level of diabetes.

show abstract

“…Two studies examined discriminant validity, but the hypothesis was reported for only one of them [22]. Known-groups validity was assessed in seven studies, with hypotheses being set in four of them [8,10,22,30].…”

Section: Hypotheses-testing Construct Validitymentioning

confidence: 99%

“…3 weeks B D-FISQ [8] 2 weeks B B K-SE-EBP [9] S-CWIS [10] 2 weeks B B B K-MSQ-Insomnia [11] 1 week B B B HL-SF12 [12] B B K-PAFAS [13] 2 weeks B B B B T-SNSI [14] 2 weeks B K-ISE [15] 2-3 weeks B B P-PTGI [16] 4 weeks B K-DCS [17] 2 weeks B B CCSN-SF [18] B B BBNE [19] T-CASSS-HB [20] 6 weeks B DSRQ-I [ Author contributions E-H.L. conceived the study and wrote the manuscript.…”

mentioning

confidence: 99%

Evaluation of Studies on the Measurement Properties of Self-Reported Instruments

Lee

Kang

2020

Asian Nursing Research

View full text Add to dashboard Cite

Psychometric Evaluation of a Turkish Version of the Diabetes Fear of Self-injecting and Self-testing Questionnaire (D-FISQ)

Cited by 8 publications

References 19 publications

The prevalence and evidence-based management of needle fear in adults with chronic disease: A scoping review

The prevalence and evidence-based management of needle fear in adults with chronic disease: A scoping review

Association between accepting the illness and effective insulin administration in patients with type 2 Diabetes Mellitus

Evaluation of Studies on the Measurement Properties of Self-Reported Instruments

Contact Info

Product

Resources

About